vs

Side-by-side financial comparison of ASCENT INDUSTRIES CO. (ACNT) and Medirom Healthcare Technologies Inc. (MRM). Click either name above to swap in a different company.

Medirom Healthcare Technologies Inc. is the larger business by last-quarter revenue ($21.1M vs $11.9M, roughly 1.8× ASCENT INDUSTRIES CO.). ASCENT INDUSTRIES CO. runs the higher net margin — -8.8% vs -21.3%, a 12.5% gap on every dollar of revenue. Medirom Healthcare Technologies Inc. produced more free cash flow last quarter ($-2.4K vs $-196.0K).

Ascent Capital Group, Inc. was a publicly traded holding company whose primary subsidiary was Monitronics. Ascent Media was a wholly owned subsidiary of the Discovery Holding Company (DHC). DHC spun off Ascent Media as an independent, public company on September 17, 2008.

Medirom Healthcare Technologies Inc. develops and delivers integrated digital health and remote patient monitoring solutions targeted at chronic disease management, post-operative care, and senior health support. It serves healthcare providers, insurance payers, and institutional care partners across key markets in North America and the Asia-Pacific region, prioritizing accessible, data-driven care to improve patient outcomes.

ACNT vs MRM — Head-to-Head

Bigger by revenue
MRM
MRM
1.8× larger
MRM
$21.1M
$11.9M
ACNT
Higher net margin
ACNT
ACNT
12.5% more per $
ACNT
-8.8%
-21.3%
MRM
More free cash flow
MRM
MRM
$193.6K more FCF
MRM
$-2.4K
$-196.0K
ACNT

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
ACNT
ACNT
MRM
MRM
Revenue
$11.9M
$21.1M
Net Profit
$-1.0M
$-4.5M
Gross Margin
14.6%
10.8%
Operating Margin
-21.0%
-28.5%
Net Margin
-8.8%
-21.3%
Revenue YoY
13.3%
Net Profit YoY
-1.2%
EPS (diluted)
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACNT
ACNT
MRM
MRM
Q4 25
$11.9M
Q3 25
$19.7M
Q2 25
$18.7M
$21.1M
Q1 25
$24.7M
Q4 24
$10.5M
Q3 24
$20.9M
Q2 24
$21.5M
Q1 24
$28.0M
Net Profit
ACNT
ACNT
MRM
MRM
Q4 25
$-1.0M
Q3 25
$-2.1M
Q2 25
$6.3M
$-4.5M
Q1 25
$-2.3M
Q4 24
$-1.0M
Q3 24
$-6.2M
Q2 24
$-926.0K
Q1 24
$-5.5M
Gross Margin
ACNT
ACNT
MRM
MRM
Q4 25
14.6%
Q3 25
29.7%
Q2 25
26.1%
10.8%
Q1 25
19.3%
Q4 24
24.3%
Q3 24
14.4%
Q2 24
13.1%
Q1 24
8.3%
Operating Margin
ACNT
ACNT
MRM
MRM
Q4 25
-21.0%
Q3 25
-4.1%
Q2 25
-14.4%
-28.5%
Q1 25
-4.2%
Q4 24
-25.4%
Q3 24
-9.4%
Q2 24
-8.6%
Q1 24
-15.5%
Net Margin
ACNT
ACNT
MRM
MRM
Q4 25
-8.8%
Q3 25
-10.6%
Q2 25
33.7%
-21.3%
Q1 25
-9.3%
Q4 24
-9.8%
Q3 24
-29.5%
Q2 24
-4.3%
Q1 24
-19.7%
EPS (diluted)
ACNT
ACNT
MRM
MRM
Q4 25
$-0.11
Q3 25
$-0.22
Q2 25
$0.65
Q1 25
$-0.23
Q4 24
$-0.11
Q3 24
$-0.61
Q2 24
$-0.09
Q1 24
$-0.54

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACNT
ACNT
MRM
MRM
Cash + ST InvestmentsLiquidity on hand
$57.6M
$252.3K
Total DebtLower is stronger
$8.8M
Stockholders' EquityBook value
$87.0M
$1.6M
Total Assets
$111.9M
$52.0M
Debt / EquityLower = less leverage
5.55×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACNT
ACNT
MRM
MRM
Q4 25
$57.6M
Q3 25
$58.0M
Q2 25
$60.5M
$252.3K
Q1 25
$14.3M
Q4 24
$16.1M
Q3 24
$8.5M
Q2 24
$3.6M
Q1 24
$1.3M
Total Debt
ACNT
ACNT
MRM
MRM
Q4 25
Q3 25
Q2 25
$8.8M
Q1 25
Q4 24
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ACNT
ACNT
MRM
MRM
Q4 25
$87.0M
Q3 25
$87.1M
Q2 25
$89.7M
$1.6M
Q1 25
$91.2M
Q4 24
$93.5M
Q3 24
$94.7M
Q2 24
$101.0M
Q1 24
$102.0M
Total Assets
ACNT
ACNT
MRM
MRM
Q4 25
$111.9M
Q3 25
$119.9M
Q2 25
$122.6M
$52.0M
Q1 25
$152.5M
Q4 24
$147.3M
Q3 24
$148.6M
Q2 24
$158.2M
Q1 24
$161.0M
Debt / Equity
ACNT
ACNT
MRM
MRM
Q4 25
Q3 25
Q2 25
5.55×
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACNT
ACNT
MRM
MRM
Operating Cash FlowLast quarter
$266.0K
$-2.3K
Free Cash FlowOCF − Capex
$-196.0K
$-2.4K
FCF MarginFCF / Revenue
-1.7%
-0.0%
Capex IntensityCapex / Revenue
3.9%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-2.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACNT
ACNT
MRM
MRM
Q4 25
$266.0K
Q3 25
$1.3M
Q2 25
$-1.4M
$-2.3K
Q1 25
$-700.0K
Q4 24
$8.8M
Q3 24
$3.4M
Q2 24
$2.2M
Q1 24
$263.0K
Free Cash Flow
ACNT
ACNT
MRM
MRM
Q4 25
$-196.0K
Q3 25
$695.0K
Q2 25
$-1.5M
$-2.4K
Q1 25
$-1.0M
Q4 24
$8.4M
Q3 24
$3.1M
Q2 24
$1.9M
Q1 24
$25.0K
FCF Margin
ACNT
ACNT
MRM
MRM
Q4 25
-1.7%
Q3 25
3.5%
Q2 25
-8.3%
-0.0%
Q1 25
-4.1%
Q4 24
80.6%
Q3 24
15.1%
Q2 24
9.1%
Q1 24
0.1%
Capex Intensity
ACNT
ACNT
MRM
MRM
Q4 25
3.9%
Q3 25
3.1%
Q2 25
0.8%
0.0%
Q1 25
1.3%
Q4 24
3.7%
Q3 24
1.3%
Q2 24
1.0%
Q1 24
0.9%
Cash Conversion
ACNT
ACNT
MRM
MRM
Q4 25
Q3 25
Q2 25
-0.22×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACNT
ACNT

Other$6.1M52%
Transferred At Point In Time$5.7M48%

MRM
MRM

Professional services expense$20.0M95%
Other$1.1M5%

Related Comparisons